Experts are rapidly focused on retatrutide, a promising medication from Eli Lilly, as a possible breakthrough in weight loss . Unlike many earlier approaches, retatrutide is a double -action receptor targeting simultaneously GLP-1 and GIP, hormones that impact appetite and blood glucose control . P